Atrial fibrillation - Public health implications

被引:33
作者
Valderrama, AL
Dunbar, SB
Mensah, GA
机构
[1] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA
[2] Ctr Dis Control & Prevent, Cardiovasc Hlth Branch, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
D O I
10.1016/j.amepre.2005.07.021
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the United States, affecting 2.3 million Americans. AF is associated with significant morbidity, mortality, and poor quality of life. AF and its treatments result in high healthcare resource use and costs. Objective: To develop a framework for public health action for the prevention, detection, and control of AF. Methods: A literature search was conducted via MEDLINE and CINAHL for the 1990-2004 period. Key words included atrial fibrillation, epidemiology, prevention, detection, treatment, and public health. Results: Published data predict a substantial increase in the prevalence of AF due to improved survival of people with coronary heart disease; increasing prevalence of hypertension, heart failure, and diabetes; and the aging of the American population. Low public awareness of AF and quality-of-care issues related to detection, control, and management are evident. Conclusions: Awareness, early detection and treatment, improved patient self-management, and attention by public health programs are essential to reduce the burden of AF. Partnerships among professional nursing and medical organizations, the Centers for Disease Control and Prevention, and patient advocacy groups represent another important approach to improving public health outcomes for AF. Hospitalizations for AF and controversies over optimal treatment strategies (e.g., rate vs rhythm control) underscore the need for both public health and applied research.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 78 条
[51]   Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life [J].
Newman, DM ;
Dorian, P ;
Paquette, M ;
Sulke, N ;
Gold, MR ;
Schwartzman, DS ;
Schaaf, K ;
Wood, K ;
Johnson, L .
AMERICAN HEART JOURNAL, 2003, 145 (05) :841-846
[52]   Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation - The results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study [J].
Opolski, G ;
Torbicki, A ;
Kosior, DA ;
Szulc, M ;
Wozakowska-Kaplon, B ;
Kolodziej, P ;
Achremczyk, P .
CHEST, 2004, 126 (02) :476-486
[53]   Atrial fibrillation and dementia in a population-based study - The Rotterdam Study [J].
Ott, A ;
Breteler, MMB ;
deBruyne, MC ;
vanHarskamp, F ;
Grobbee, DE ;
Hofman, A .
STROKE, 1997, 28 (02) :316-321
[54]   Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation [J].
Paquette, M ;
Roy, D ;
Talajic, M ;
Newman, D ;
Couturier, A ;
Yang, C ;
Dorian, P .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (07) :764-768
[55]  
PAQUETTE M, 1999, PACE, V22, P863
[56]   Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm [J].
Pozzoli, M ;
Cioffi, G ;
Traversi, E ;
Pinna, GD ;
Cobelli, F ;
Tavazzi, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :197-204
[57]   Cardioversion of atrial fibrillation to sinus rhythm: Who, when, how, and why? [J].
Prystowsky, EN .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (03) :326-+
[58]  
Psaty BM, 1997, CIRCULATION, V96, P2455
[59]   Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation [J].
Redfield, MM ;
Kay, GN ;
Jenkins, LS ;
Mianulli, M ;
Jensen, DN ;
Ellenbogen, KA .
MAYO CLINIC PROCEEDINGS, 2000, 75 (08) :790-795
[60]  
*RES CTR STROK HEA, TAK YOUR PULS LIF